• SURGICAL INTERVENTIONS FOR MODERATE ISCHEMIC MITRAL REGURGITATION

• ​​Surgical Ablation Versus No Surgical Ablation for Patients with Persistent or Longstanding Persistent Atrial Fibrillation Undergoing Mitral Valve Surgery

• ​​Evaluation of Outcomes Following Mitral Valve Repair/Replacement in Severe Chronic Ischemic Mitral Regurgitation

• ​​LVAD Therapy: Exploring the Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function

• ​​Management Practices and the Risk of Infections Following Cardiac Surgery

• ​​Hybrid Revascularization Observational Study

• ​​Rate Control Versus Rhythm Control for Postoperative Atrial Fibrillation

• ​​Neuroprotection In Patients Undergoing Aortic Valve Replacement

• ​Ten-year outcomes of the Arterial Revascularisation Trial revealed today

​

• ARRIVE: Aspirin to Reduce Risk of Initial Vascular Events

• ASCEND Aspirin: A Study of Cardiovascular Events in Diabetes

• ASCEND Omega-3: A Study of Cardiovascular Events in Diabetes

• CABANA: Catheter ABlation vs ANtiarrhythmic Drug Therapy in Atrial Fibrillation

• CIRT: Cardiovascular Inflammation Reduction Trial

• COAPT: Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation

​

• DECLARE-TIMI 58: Dapagliflozin Effect on Cardiovascular Events–Thrombolysis in Myocardial Infarction 58

• ODYSSEY OUTCOMES: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With

  • Alirocumab

• REDUCE-IT: Reduction of Cardiovascular Events With Icosapent Ethyl–Intervention Trial

• REGROUP: Randomized Endovein Graft Prospective

  • SMART-DATE: Safety of 6-Month Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes

​

• ​Antithrombotic Therapy After Acute Coronary Syndrome or PCI in Atrial Fibrillation 

• Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease

• Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

• Early Surgery or Conservative Care for Asymptomatic Aortic Stenosis

• Complete Revascularization with Multivessel PCI for Myocardial Infarction

• Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease

• A Fully Magnetically Levitated Left Ventricular Assist Device — Final Report

• Randomized Comparison of Ticagrelor versus Prasugrel in Patients with Acute Coronary Syndrome and Planned Invasive Strategy—Design and Rationale of the Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (ISAR-REACT) 5 Trial

• Ticagrelor with or without Aspirin in High-Risk Patients after PCI

• Antibacterial Envelope to Prevent Cardiac Implantable Device Infection